Icosavax, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Icosavax, Inc.
Quantité totale PI 39
Rang # Quantité totale PI 37 011
Note d'activité PI 2,6/5.0    45
Rang # Activité PI 16 263
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

13 2
8 0
14 0
2
 
Dernier brevet 2025 - Protein-based nanoparticle vacci...
Premier brevet 2021 - Method of making virus-like part...
Dernière marque 2021 - ICOSAVAX
Première marque 2021 - ICOSAVAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Protein-based nanoparticle vaccine for metapneumovirus. Provided are virus-like particle vaccine...
Invention Rabies g protein and uses thereof. Provided are polypeptide comprising a rabies G protein ectodo...
Invention Protein nanostructure vaccine. Neisseria meningitidisNeisseria meningitidis.Neisseria meningitidis.
Invention Protein nanostructure vaccine. Provided are protein nanostructures that display Neisseria mening...
2024 Invention Nanostructure-forming polypeptides and uses thereof. The present disclosure relates to polypeptid...
Invention Nanostructure-forming polypeptides and uses thereof. The present disclosure relates to polypepti...
Invention Multivalent vaccine for paramyxoviruses and uses thereof. Provided are compositions pharmaceutic...
Invention Viral proteins and nanostructures and uses thereof. Provided herein are recombinant polypeptides...
Invention Respiratory syncytial virus f proteins and nanostructures and uses thereof. Provided herein are ...
Invention Viral proteins and nanostructures and uses thereof. Provided herein are recombinant polypeptides ...
Invention Respiratory syncytial virus f proteins and nanostructures and uses thereof. Provided herein are r...
Invention Influenza neuraminidase tetramers. The disclosure relates to compositions that include a recombin...
Invention Coronavirus spike glycoprotein receptor binding domains and uses thereof. The disclosure relates ...
2023 Invention Antibodies against metapneumovirus fusion (f) protein and uses thereof. Provided are epitope-spec...
Invention Protein-based nanoparticle vaccine for metapneumovirus. Provided are virus-like particle vaccines...
Invention Rabies g protein and uses thereof. Provided are polypeptide comprising a rabies G protein ectodom...
Invention Multivalent vaccine for paramyxoviruses and uses thereof. Provided are compositions pharmaceutica...
2022 Invention Virus-like particle vaccine for respiratory syncytial virus. The present disclosure relates to t...
Invention Virus-like particle vaccine for respiratory syncytial virus. The present disclosure relates to ta...
Invention Virus-like particle vaccine for coronavirus. The present disclosure relates to targeting SARS-Co...
Invention Virus-like particle vaccine for coronavirus. The present disclosure relates to targeting SARS-CoV...
2021 Invention Protein-based nanoparticle vaccine for metapneumovirus. e.g.e.g., immunizing a subject to generat...
P/S Pharmaceutical preparations; vaccines. Medical apparatus. Medical research and development primar...
Invention Method of making virus-like particle. Disclosed is a method of making a nanostructure by solubil...
Invention Method of assemblying two-component virus-like particle. Disclosed are methods of a method of ma...
Invention Method of making virus-like particle. Disclosed is a method of making a nanostructure by solubili...
Invention Method of assemblying two-component virus-like particle. Disclosed are methods of a method of mak...
P/S Medical research and development primarily for the benefit of others in the fields of vaccines, b...